DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine
- PMID: 11049087
DNA intercalation, topoisomerase II inhibition and cytotoxic activity of the plant alkaloid neocryptolepine
Abstract
Cryptolepine and neocryptolepine are two indoloquinoline alkaloids isolated from the roots of the African plant Cryptolepis sanguinolenta. Both drugs have revealed antibacterial and antiparasitic activities and are strongly cytotoxic to tumour cells. We have recently shown that cryptolepine can intercalate into DNA and stimulates DNA cleavage by human topoisomerase II. In this study, we have investigated the mechanism of action and cytotoxicity of neocryptolepine, which differs from the parent isomer only by the orientation of the indole unit with respect to the quinoline moiety. The biochemical and physicochemical results presented here indicate that neocryptolepine also intercalates into DNA, preferentially at GC-rich sequences, but exhibits a reduced affinity for DNA compared with cryptolepine. The two alkaloids interfere with the catalytic activity of human topoisomerase II but the poisoning activity is slightly more pronounced with cryptolepine than with its isomer. The data provide a molecular basis to account for the reduced cytotoxicity of neocryptolepine compared with the parent drug.
Similar articles
-
Stimulation of topoisomerase II-mediated DNA cleavage by three DNA-intercalating plant alkaloids: cryptolepine, matadine, and serpentine.Biochemistry. 1999 Jun 15;38(24):7719-26. doi: 10.1021/bi990094t. Biochemistry. 1999. PMID: 10387011
-
The DNA intercalating alkaloid cryptolepine interferes with topoisomerase II and inhibits primarily DNA synthesis in B16 melanoma cells.Biochemistry. 1998 Apr 14;37(15):5136-46. doi: 10.1021/bi972927q. Biochemistry. 1998. PMID: 9548744
-
Cytotoxicity and cell cycle effects of the plant alkaloids cryptolepine and neocryptolepine: relation to drug-induced apoptosis.Eur J Pharmacol. 2000 Dec 1;409(1):9-18. doi: 10.1016/s0014-2999(00)00805-0. Eur J Pharmacol. 2000. PMID: 11099695
-
Recent developments in naturally derived antimalarials: cryptolepine analogues.J Pharm Pharmacol. 2007 Jun;59(6):899-904. doi: 10.1211/jpp.59.6.0017. J Pharm Pharmacol. 2007. PMID: 17637183 Review.
-
Indoloquinolines as scaffolds for drug discovery.Curr Med Chem. 2010;17(22):2348-70. doi: 10.2174/092986710791698521. Curr Med Chem. 2010. PMID: 20491639 Review.
Cited by
-
Synthesis and In Vitro Antiproliferative Activity of 11-Substituted Neocryptolepines with a Branched ω-Aminoalkylamino Chain.Molecules. 2017 Nov 12;22(11):1954. doi: 10.3390/molecules22111954. Molecules. 2017. PMID: 29137152 Free PMC article.
-
Structural Modifications of Nature-Inspired Indoloquinolines: A Mini Review of Their Potential Antiproliferative Activity.Molecules. 2019 Jun 5;24(11):2121. doi: 10.3390/molecules24112121. Molecules. 2019. PMID: 31195640 Free PMC article. Review.
-
Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients.Invest New Drugs. 2009 Oct;27(5):402-11. doi: 10.1007/s10637-008-9185-5. Epub 2008 Oct 14. Invest New Drugs. 2009. PMID: 18853102
-
Synthesis and Evaluation of the Tetracyclic Ring-System of Isocryptolepine and Regioiso-Mers for Antimalarial, Antiproliferative and Antimicrobial Activities.Molecules. 2021 May 30;26(11):3268. doi: 10.3390/molecules26113268. Molecules. 2021. PMID: 34070798 Free PMC article.
-
Design and cytotoxic evaluation via apoptotic and antiproliferative activity for novel 11(4-aminophenylamino)neocryptolepine on hepatocellular and colorectal cancer cells.Apoptosis. 2023 Apr;28(3-4):653-668. doi: 10.1007/s10495-023-01810-y. Epub 2023 Jan 31. Apoptosis. 2023. PMID: 36719468
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Miscellaneous